Curr cancer drug targets 影响因子

WebCurrent Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets ... WebMay 31, 2024 · Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer treatments. Since the first tyrosine kinase ...

Current Research in Pharmacology and Drug Discovery

WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ... WebThe current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular targeting agents. In addition, promising drug candidates under … how long brakes on car last https://deardrbob.com

Expert Opinion on Therapeutic Targets Taylor & Francis Online

WebAug 15, 2024 · BTC is a rare and aggressive cancer disease, bearing an overall dismal prognosis with only finite therapy options. Only combination chemotherapy regimens achieve disease control, which is often only short-lived since the tumor tissue exhibits high resistance to chemotherapy. ... Curr Cancer Drug Targets. 2024 Aug 15;22(8):639-650. … WebAug 17, 2024 · 肿瘤学（ONCOLOGY）领域SCIE期刊及2024年影响因子排名part1. 哪些肿瘤学（ONCOLOGY）SCI期刊容易发表？. 影响因子是衡量期刊水平的重要指标，一般 … WebApr 5, 2024 · Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.. The journal … how long break am i entitled to

Current Cancer Drug Targets Bentham Science

Category:Current Cancer Drug Targets Bentham Science

Tags:Curr cancer drug targets 影响因子

Curr cancer drug targets 影响因子

手慢无！这本无需版面费的3分期刊从投稿到出版最快10 …

Web影响因子 IF 热搜. 2 ... Biomimetics Cell Stem Cell Pharmaceutical Biology PPAR Research Pharmacogenetics and Genomics Archives of Pharmacal Research Current Cancer Drug Targets Pharmacogenomics Journal EXCLI Journal Journal of Pharmacological Sciences MedChemComm Phytochemical Analysis Molecular Imaging Molecular ... pre-clinical … WebCurr Cancer Drug Targets. 2013 Jan;13(1):30-47. Authors ... Other drugs to consider are thalidomide, lenalidomide, antiangiogenic agents, tyrosine kinase inhibitors and heat shock protein 90 inhibitors, which all have both antileukemic and immunomodulatory effects. Relatively few clinical studies are available for patients with this high-risk ...

Curr cancer drug targets 影响因子

Did you know?

Web期刊名称. CURR PROB CANCER/CURRENT PROBLEMS IN CANCER. ISSN. 0147-0272. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 6.769 （MedSci实时期刊指数） 5.25578 （5年期刊指数）. WebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：一般,3-8周 平均录用比例：网友分享经验：较难 在线出版周期：

http://www.nativeee.com/index.php/news/434.html WebApr 8, 2024 · 《journal of drug targeting》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《j drug target》" 杂志的可信度。学术期刊真正的价值在于 …

WebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：平均1月 平均录用比例：网友分享经验：约50% 在线出版周期： Web在文章类型上，论著和综述文章是大头，数量参半，还有少量的社论文章。Web of Science已收录的文章中，论著文章1308篇，综述文章1109篇。 影响因子. 2024年6月，Cancers与Cells杂志同时获得首个SCI影响因子，Cancers的分数略高，而且破5分，这关注度自然要更 …

WebCURRENT CANCER DRUG TARGETS. 出版年份：2001 年文章数：29 投稿命中率：43.75%. 出版周期：Monthly 自引率：1.2% 审稿周期：平均2.4月. 前往期刊查询. 期刊 …

WebThis journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. how long bread keeps in freezerWebTargeting the ubiquitin-proteasome pathway has emerged as a rational approach in the treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib was subsequently approved for the clinical use as a front-line treatment for newly diagnosed multiple myeloma patients and for the treatment of relapsed/refractory multiple myeloma … how long break for 9 hour shiftWebAbstract. Background: Multiple myeloma (MM) is a hematological cancer caused by a proliferation of clonal plasma cells, leading to anemia, renal failure, hypercalcemia and destructive bone lesions resulting in significant morbidity. The overall survival has significantly improved with the incorporation of immunomodulatory drugs (IMiDs) and ... how long breast milk in freezerWebCurr Cancer Drug Targets. 2024;21(7):558-574. doi: 10.2174/1568009621666210504091722. ... The microenvironment of gliomas includes non-cancer cells such as immune cells, fibroblasts, and cells of blood vessels, as well as secreted molecules and the extracellular matrix, and all these components play a vital … how long bread takes to bakeWeb介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics … how long brine chicken legsWebTargeting highly proliferating cells is an important issue for many types of aggressive tumors. Proliferating Cell Nuclear Antigen (PCNA) is an essential protein that participates in a variety of processes of DNA metabolism, including DNA replication and repair, chromatin organization and transcription and sister chromatid cohesion. how long brine turkeyWebCurrent Research in Pharmacology and Drug Discovery (CRPHAR) is a new primary research, gold open access journal from Elsevier. CRPHAR publishes original papers, … how long breastmilk ok room temp